DoD Tick-Borne Disease, Idea Development Award
ID: 353715Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353715
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 23, 2024, 12:00 AM UTC
  4. 4
    Due Oct 3, 2024, 12:00 AM UTC
Description

The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Tick-Borne Disease Research Program (TBDRP) Idea Development Award, aimed at supporting innovative research to combat Lyme disease and other tick-borne diseases. This grant seeks proposals that introduce novel concepts or challenge existing paradigms, with a focus on enhancing understanding, prevention, and treatment of these diseases, particularly in military contexts. With an estimated total program funding of $3.64 million and the expectation of awarding five grants, interested applicants must submit a pre-application by June 26, 2024, followed by a full application by invitation due by October 3, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

Point(s) of Contact
help@eBRAP.org
Files
Title
Posted
HT942524TBDRPIDA_GG.pdf
Aug 24, 2024, 2:22 AM UTC
The Department of Defense (DOD) is seeking proposals for the FY24 Tick-Borne Disease Research Program (TBDRP) through its Idea Development Award, aimed at innovative research addressing Lyme disease and other tick-borne conditions. With a funding pool of $7 million, the program encourages novel approaches to enhance understanding, prevention, and treatment of these diseases, specifically addressing issues such as disease pathogenesis, treatment innovations, and diagnostics. Applications must be submitted in two stages: a pre-application by June 26, 2024, followed by a full application upon invitation by October 3, 2024. Eligible applicants include both extramural and intramural organizations, with principal investigators ideally holding independent researcher roles or being early-career scientists supported by experienced mentors. The DOD emphasizes the significance of research addressing the public health burden of tick-borne diseases, particularly in military contexts, and supports collaboration with DOD and VA research programs. Awards are targeted to produce impactful discoveries that enhance patient care and public health outcomes related to tick-borne diseases.
Similar Opportunities
DOD Amyotrophic Lateral Sclerosis, Therapeutic Development Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) to support innovative research aimed at developing therapies for Amyotrophic Lateral Sclerosis (ALS). This grant program seeks applications that demonstrate proof-of-concept efficacy in preclinical models of ALS, with a focus on empirical therapeutic studies and the development of mechanism-specific biomarkers to enhance trial design and patient selection. With an estimated total funding of approximately $9.8 million, the program anticipates awarding about four grants, each capped at $1.5 million for a maximum duration of three years. Interested applicants must submit a pre-application by June 6, 2025, followed by a full application due by August 27, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
Dept. of the Army -- USAMRAA
The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRDC), has announced the FY23-FY27 Broad Agency Announcement (BAA) for Extramural Medical Research, which is open for submissions from October 1, 2022, to September 30, 2027. This opportunity invites innovative research proposals that address critical military medical challenges, particularly in the areas of Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine, with a focus on enhancing medical practices for both military personnel and civilians. The BAA emphasizes the importance of collaboration with Department of Defense and Department of Veterans Affairs resources and requires adherence to strict submission guidelines via Grants.gov and the electronic Biomedical Research Application Portal (eBRAP). Interested applicants can submit pre-proposals at any time during the five-year period, with full proposals invited based on initial submissions, and should direct inquiries to the CDMRP Help Desk at help@eBRAP.org.
Alzheimer’s Research Program Transforming Research Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Research Award to support innovative research aimed at reducing the risk of Alzheimer's disease and related dementias (AD/ADRD). This grant opportunity encourages diverse applicants, including for-profit, non-profit, and academic institutions, and emphasizes the necessity of community collaboration, particularly for clinical research projects. With an estimated total program funding of $4 million, the program anticipates awarding approximately four grants, each providing up to $1 million over a maximum of three years. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due by August 29, 2025. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
DoD Breast Cancer Breakthrough Award Level 3
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Breast Cancer Breakthrough Award Level 3, aimed at supporting innovative research with the potential to significantly advance breast cancer treatment and prevention. Applicants are required to address at least one of the Department of Defense-defined challenges related to breast cancer, and the research team must include breast cancer consumer advocates to ensure patient perspectives are integrated into the research process. This grant program allocates approximately $27.9 million for three awards, with funding caps of $4 million for single Principal Investigators and $5 million for projects involving a Partnering PI. Pre-applications are due by June 13, 2025, and full applications must be submitted by September 10, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
Alzheimer’s Research Program Transforming Diagnosis Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Diagnosis Award to support innovative research aimed at enhancing the diagnosis and prognosis of Alzheimer's disease and related dementias (AD/ADRD). This grant opportunity encourages community collaboration and requires the submission of preliminary data, with a focus on addressing barriers to effective dementia diagnosis. With an estimated total program funding of $3.2 million, the program anticipates awarding two grants, with funding caps set at $1.5 million for single Principal Investigator (PI) proposals and $1.7 million for those utilizing the Career Initiation or Transition Partnership Option. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due by August 29, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
Alzheimer’s Research Program Transforming Care Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Care Award to support innovative clinical research aimed at improving care for individuals with Alzheimer's disease and related dementias (AD/ADRD). This funding opportunity encourages community collaboration and requires projects to focus on interventions that enhance the quality of life for both patients and their caregivers. Approximately $5.2 million is available to fund around three awards, with pre-applications due by June 12, 2025, and full applications due by August 29, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
DoD Breast Cancer Breakthrough Award Levels 1 and 2
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Breast Cancer Research Program (BCRP) Breakthrough Award Levels 1 and 2, aimed at supporting innovative research with the potential to significantly advance breast cancer treatment and prevention. This funding opportunity, totaling approximately $37.7 million, seeks to address critical challenges in breast cancer research, including prevention strategies, understanding metastasis, and improving treatment efficacy. Eligible applicants include both domestic and foreign nonprofit and for-profit organizations, with a strong emphasis on collaborative partnerships, particularly those involving military and veteran populations. Interested parties must submit a pre-application by June 13, 2025, followed by a full application due by June 27, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
DOD Amyotrophic Lateral Sclerosis, Clinical Outcomes and Biomarkers Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is inviting applications for the Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA) for fiscal year 2025. This grant aims to support the development and validation of clinical outcomes and biomarkers specifically for enhancing clinical trials in Amyotrophic Lateral Sclerosis (ALS), focusing on targeted therapies or genetic mutations rather than broad applicability to all patients. With an estimated total program funding of $6.2 million, the program anticipates awarding approximately five grants, each with a maximum budget of $750,000 for a duration of up to three years. Interested applicants must submit a pre-application by June 6, 2025, followed by a full application due by August 27, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
DOD Ovarian Cancer, Pilot Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Ovarian Cancer Research Pilot Award, aimed at fostering innovative research in ovarian cancer. This grant opportunity encourages projects that explore groundbreaking concepts and approaches to enhance early detection and prevention strategies, with a focus on significant advancements that can impact patient care. The total funding available is approximately $3.15 million, with nine awards anticipated, each capped at $350,000 for a maximum duration of two years. Interested applicants must submit a pre-application by June 12, 2025, followed by full applications due by September 11, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at 301-682-5507 or via email at help@eBRAP.org.
DOD Ovarian Cancer, Investigator-Initiated Research Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award for fiscal year 2025. This grant aims to support innovative research that addresses critical needs in ovarian cancer care, with a focus on areas such as ovarian cancer biology, novel therapies, prevention strategies, early detection, and enhancing patient survivorship. The program is significant for advancing ovarian cancer research and improving care for service members and the broader community. Interested applicants can submit a pre-application by June 12, 2025, with full applications due by September 11, 2025. The estimated total program funding is $8,050,000, with individual awards up to $1.05 million for single Principal Investigators and $1.4 million for partnering PIs, and preliminary data is required to demonstrate the scientific validity of the proposed research. For further inquiries, applicants can contact the CDMRP Help Desk at 301-682-5507 or via email at help@eBRAP.org.